Expert Group Publishes Guidelines for Evaluating Pathogenicity of Sequence Variants | GenomeWeb

NEW YORK (GenomeWeb) − A group of mostly US-based genomics and clinical sequencing experts has put forward a set of guidelines for determining whether a rare sequence variant is causally linked to a disease.

The guidelines, which they plan to follow up with more specific ones in the future, were published in Nature last week. They resulted from a workshop held by the National Human Genome Research Institute in September 2012.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.